Related Experiment Video
Updated: Jun 9, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Luspatercept in Transfusion-Dependent Thalassemia With Red Blood Cell Antibodies: A Case Series
1Division of Hematology Department of Internal Medicine Srinagarind Hospital Faculty of Medicine Khon Kaen University Khon Kaen Thailand.
Red blood cell (RBC) antibodies complicate transfusion support in transfusion-dependent thalassemia (TDT), and data on luspatercept in this setting remain limited. We retrospectively reviewed seven adults with TDT and RBC antibodies treated with luspatercept at Srinagarind Hospital from January 2025 to January 2026. Baseline transfusion need was six packed RBC units/12 weeks in all patients. During weeks 13-24, six patients achieved a clinically meaningful reduction, with a median decrease of three units/12 weeks (range, 2-5; median 50.0%). Responses were greatest without warm autoantibodies. No new alloantibodies or serious adverse events were observed. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Red blood cell (RBC) antibodies complicate transfusion support in transfusion-dependent thalassemia (TDT), and data on luspatercept in this setting remain limited. We retrospectively reviewed seven adults with TDT and RBC antibodies treated with luspatercept at Srinagarind Hospital from January 2025 to January 2026. Baseline transfusion need was six packed RBC units/12 weeks in all patients. During weeks 13-24, six patients achieved a clinically meaningful reduction, with a median decrease of three units/12 weeks (range, 2-5; median 50.0%). Responses were greatest without warm autoantibodies. No new alloantibodies or serious adverse events were observed. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
